DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Otros (Other)
A lyophilized open-source RT-LAMP assay for molecular diagnostics in resource-limited settings
A critical bottleneck for equitable access to population-scale molecular diagnostics is the limited
availability of rapid, inexpensive point-of-care tests especially in low- and middle-income countries. Here,
we developed an open-source Reverse transcription loop-mediated isothermal amplification (RT-LAMP)
molecular assay for the detection of respiratory RNA virus infections. It is based on non-proprietary
enzymes, namely HIV-1 reverse transcriptase, Bst LF DNA polymerase and UDG BMTU thermolabile
uracil DNA glycosylase. Formulated as liquid or lyophilized reaction mixtures, these reagents enable
sensitive colorimetric detection of respiratory samples without the need for prior nucleic acid isolation. We
evaluated our open-source lyophilized RT-LAMP assay on clinical samples with suspected COVID-19
infection, demonstrating high sensitivity and 100% specificity compared to the gold standard Reverse
transcription quantitative polymerase chain reaction (RT-qPCR). Reaction performance was unaffected by
prolonged storage of lyophilized reagents at ambient or elevated temperatures. As a proof of concept, we
evaluated the robustness and ease-of-use of lyophilized RT-LAMP reaction mixes through independent
laboratory testing of COVID-19 samples in Ghana. Overall, our open-source RT-LAMP assay provides a
flexible and scalable point-of-care test that can be adapted for rapid detection of various pathogens in
resource-limited settings., M.M. and M.J.K. were supported by the Vienna Science and Technology Fund (WWTF) through project
COV20-031. This project received funding from the VW foundation (grant # 9A027) given to TReND in
Africa, as well as funding from the "Mila Charitable Organisation". The IMP receives generous institutional
funding from Boehringer Ingelheim and the Austrian Research Promotion Agency (Headquarter grant FFG852936), and IMBA is generously supported by the Austrian Academy of Sciences. Research in the lab of
A.P. was supported by the Austrian Science Fund (START Projekt Y 1031-B28, SFB “RNA-Deco” F 80). Research in the lab of J.B. was supported by the European Research Council (ERC2015-CoG - 682181).
F.A and G.A.A. were supported by a Science for Africa Foundation (SFA)/Wellcome Developing
Excellence in Leadership Training and Science (DELTAS) in Africa grant (DEL-22-014: Awandare, G).
Work in the L.M.-A. laboratory was supported by grant PID2019104176RBI00/AEI/10.13039/501100011033 of the Spanish Ministry of Science and Innovation, and an institutional
grant of the Fundación Ramón Areces. The laboratory of J.M.P. at IMBA received funding from the
Austrian Academy of Sciences, the Medical University of Vienna, the Swedish Research Council (2018-
05766), the T. von Zastrow foundation, and the Innovative Medicines Initiative 2 Joint Undertaking under
grant agreement No 101005026. This Joint Undertaking receives support from the European Union’s
Horizon 2020 research and innovation programme and EFPIA., No